Crossref
Reassessing Age as a Barrier: Real-World Evidence of Chemotherapy and Immunotherapy in Older Adults
Malignancy Spectrum · 2026 · 3 (2) · 89
DOI: 10.15302/msp.2026.0009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Malignancy Spectrum, 2026. Verfasst von Haider Imran und 3 weiteren Autor:innen. Die Arbeit nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Imran, H., Haque, Z. A., Mazhar, M. O., & Aslam, M. A. (2026). Reassessing Age as a Barrier: Real-World Evidence of Chemotherapy and Immunotherapy in Older Adults. Malignancy Spectrum, 3(2), 89. https://doi.org/10.15302/msp.2026.0009
Vancouver
Imran H, Haque ZA, Mazhar MO, Aslam MA. Reassessing Age as a Barrier: Real-World Evidence of Chemotherapy and Immunotherapy in Older Adults. Malignancy Spectrum. 2026;3(2):89. doi:10.15302/msp.2026.0009
BibTeX
@article{Imran2026,
author = {Imran, Haider and Haque, Zahra Ali and Mazhar, Muhammad Owais and Aslam, Muhammad Aatir},
title = {Reassessing Age as a Barrier: Real-World Evidence of Chemotherapy and Immunotherapy in Older Adults},
journal = {Malignancy Spectrum},
year = {2026},
volume = {3},
number = {2},
pages = {89},
doi = {10.15302/msp.2026.0009}
}
EUVIMED